8-KItem 5.02 · Officer/Director ChangeItem 9.01 · Financial Statements

Regeneron grants CEO and CSO 10-year performance share awards

Filed with the SEC on · Summarized by InvestorsBot

Effective September 24, 2026, Regeneron granted one-time performance share unit awards to CEO Leonard Schleifer and CSO George Yancopoulos, with maximum awards of 2.7 million and 2.9 million shares, respectively. The awards run through December 31, 2035, are tied to new product filings, approvals and revenue of up to $30 billion, include a potential 20% relative TSR adjustment, and replace additional annual equity awards through 2036. Regeneron also formed a majority-controlled subsidiary for a potential non-core opportunity and gave both executives equity stakes, but the entity currently has nominal value, no significant assets and has not begun operations.

Read the original filing on SEC EDGAR

Get summaries like this in your inbox every morning

Pick up to 20 companies — we read their SEC filings overnight and send you the plain-English version. Free.

Subscribe free

More from REGENERON PHARMACEUTICALS, INC.